[1]
M. . Iqbal Anand, “SGLT2 INHIBITORS DECREASE CARDIOVASCULAR DEATH AND HEART FAILURE HOSPITALIZATIONS: A SYSTEMATIC REVIEW”, JARMHS, vol. 8, no. 11, pp. 7–13, Nov. 2022, doi: 10.53555/nnmhs.v8i11.1398.